New approaches for diagnostic of chronic obstructive pulmonary disease
Abstract
The present study refers to the exploration of the respiratory function of patients who presented acute symptoms of chronic obstructive pulmonary disease. In the medical specialty units, examination was performed using a standard chest X-ray imaging investigation; followed by a spirometry test, according to the patient's severity of symptoms, using the betamimetics test. Both the X-ray result and the imaging investigation of spirometry showed changes. Changes varied according to the patients from different investigate disease groups in relation to chronic obstructive pulmonary disease.
About the Authors
A. Cheşcă
Transilvania University of Braşov
Romania
Romania
Antonella Cheşcă – Head of Imagistics Lab. at Lung Phthysiology Hospital
Braşov
S. A. Cheşcă
Psychiatry and Neurology Hospital Braşov
Romania
Romania
T. Sandle
University of Manchester
United Kingdom
United Kingdom
References
1. Baker W. L. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis /W. L. Baker, E. L. Baker, C. I. Coleman //Pharmacotherapy. – 2009. – V. 29(8). – P. 891-905.
2. Chen A. M. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease /A. M. Chen, S. G. Bollmeier, P. M. Finnegan //Ann. Pharmacother. – 2008. – V. 42(12). – P. 1832-1842.
3. Ciappi G. Functional diagnosis of chronic obstructive pulmonary disease /G. Ciappi, G. Corbo, S. Valente //Ann. Ist. Super. Sanita. – 2003. – V. 39(4). – P. 529-547.
4. Cooper C. B. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease /C. B. Cooper, M. Dransfield //Am. J. Med. – 2008. – V. 121. – P. 33-45.
5. Hurst J. R. Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review /J. R. Hurst, J. A. Wedzicha //BMC Med. – 2009. V. 7. – P. 40.
6. Izumi T. Definition of chronic obstructive disease //Nihon Rinsho. – 2003. – V. 61(12). – P. 2058-2070.
7. Puhan M. A. drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis /M. A. Puhan, L. M. Bachmann, J. Kleijnen //BMC Med. – 2009. – V. 7. – P. 2.
8. Reddy C. B. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease? /C. B. Reddy, R. E. Kanner //Drugs Aging. – 2007. – V. 24(8). – P. 615-628.
9. Romagnoli M. Chronic obstructive pulmonary disease: definition and classification of severity /M. Romagnoli, L. M. Fabbri //Ann. Ist. Super Sanita. – 2003. – V. 39(4). – P. 461-466.
10. Sethi S. Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease /S. Sethi, C. Cote //Curr. Clin. Pharmacol. – 2011. – V. 6(1). – P. 48-61.
11. Yoshida M. General concepts and the history of chronic obstructive pulmonary disease //Nihon Kyobu Shikkan Gakkai Zasshi. – 1990. – V. 28(3). – P. 390-398.
12. Yu T. Support of personalized medicine through risk-stratified treatment recommendations – an environmental scan of clinical practice guidelines /T. Yu, D. Vollenweider, R. Varadhan //BMC Med. – 2013. – V. 11. – P. 7.
Review
For citations:
Cheşcă A., Cheşcă S.A., Sandle T. New approaches for diagnostic of chronic obstructive pulmonary disease. Medicine and ecology. 2021;(4):26-30.
Views: 185
Email this article 